Written question asked by James Naish (Labour) on Friday, 4 September 2026, in the House of Commons. It was due for an answer on Friday, 11 September 2026 (named day). It was answered by James Frith (Labour) on Friday, 11 September 2026 on behalf of the Department of Health and Social Care.
Colestyramine: Prescriptions
- Question
-
To ask the Secretary of State for Health and Social Care, if she will make an assessment of the potential impact of the reported withdrawal of the original formulation of Questran from the UK market on patients with bile acid malabsorption.
Secondary information
- Type
- Written question
- Reference
- 27288
- Session
- 2026-27
- Related items
- Grouped for answer
- Yes
- Subjects
- Prescriptions Colestyramine
- Link
- View this Written question on www.parliament.uk
Librarians' tools
- Timestamp
- 2026-09-11 15:01:10 +0100
- URI
- http://data.parliament.uk/writtenparliamentaryquestion/commons/2026-27/27288
- In Indexing
- http://indexing.parliament.uk/Content/Edit/1?uri=http://data.parliament.uk/writtenparliamentaryquestion/commons/2026-27/27288
- In Solr
- https://search.parliament.uk/claw/solr/?id=http://data.parliament.uk/writtenparliamentaryquestion/commons/2026-27/27288